Market Cap 5.29B
Revenue (ttm) 4.09B
Net Income (ttm) 55.76M
EPS (ttm) N/A
PE Ratio 32.55
Forward PE 17.09
Profit Margin 1.36%
Debt to Equity Ratio 0.29
Volume 516,565
Avg Vol 1,558,208
Day's Range N/A - N/A
Shares Out 156.62M
Stochastic %K 97%
Beta -0.68
Analysts Strong Sell
Price Target $44.20

Company Profile

PACS Group, Inc., through its subsidiaries, operates skilled nursing facilities and assisted living facilities in the United States. It also provides senior care and independent living facilities. The company engages in the acquisition, ownership, and leasing of health care-related properties. The company was founded in 2013 and is headquartered in Farmington, Utah.

Industry: Medical Care Facilities
Sector: Healthcare
Phone: 801 447 9829
Website: pacs.com
Address:
262 North University Avenue, Farmington, United States
DrabCrab5
DrabCrab5 Feb. 3 at 6:39 PM
$PACS a fine shelter in the absolute shit show that is today across tech / software.
0 · Reply
DrabCrab5
DrabCrab5 Jan. 30 at 9:03 PM
$PACS now that we’re back down in the mid $30’s thought it was as good a time as ever to share an updated version of the below. A lot will depend on the 2026 outlook, but I’m not sure why this wouldn’t trade back up to the mid $40’s in due time.
1 · Reply
Beansboy
Beansboy Jan. 29 at 3:18 PM
$PACS seriously where is the bottom here? How can it sell off like this every single day for 3 weeks straight?
2 · Reply
Beansboy
Beansboy Jan. 28 at 2:59 PM
$PACS such blatant price manipulation. Notice how every single time it’s green it’s immediately knocked significantly back into red. Been doing this nearly every single day since 1/12. Couldn’t be anymore obvious. Someone is trying to keep the share price suppressed.
1 · Reply
Beansboy
Beansboy Jan. 27 at 9:31 PM
$PACS I think this has been unfairly beaten down. Going to guess it’s a mix of profit taking and market makers pushing this down easily for a cheaper entry. Hope it can get back to $40 on its own. Also hope they give us some preliminary Q4 2025 results in Feb.
0 · Reply
mrtatham
mrtatham Jan. 26 at 7:07 AM
$PACS so you’re telling me that the short interest for March 20 is sitting almost 96% in $25 Puts????? They are 100% disclosing information about the investigation next earnings that is not going to be good. Insiders loaded to the gills on puts.
1 · Reply
DrabCrab5
DrabCrab5 Jan. 21 at 7:04 PM
$PACS company announced the acquisition of 3 new facilities as well as the underlying real estate of two of those facilities. They also exercised the right to acquire the real estate for two separate facilities they already owned the operations of. Would love to see a few more facility tuck ins before Q4 results are announced.
0 · Reply
DrabCrab5
DrabCrab5 Jan. 20 at 8:53 PM
$PACS pretty confused at this point… names I follow that are much more sensitive to broader economic conditions, tariffs, etc. are not down near this much. Should be holding up better as a defensive, non-discretionary name but so be it I guess.
1 · Reply
DrabCrab5
DrabCrab5 Jan. 20 at 6:34 PM
$PACS a 15% drop off the high this week vs. $ENSG at more like 2.5% off its weekly high is feeling prettyyy egregious
0 · Reply
inksquid
inksquid Jan. 20 at 2:36 PM
$PACS Put options are cheap
0 · Reply
Latest News on PACS
PACS Group Announces Business Updates

Dec 1, 2025, 4:15 PM EST - 2 months ago

PACS Group Announces Business Updates


PACS Group, Inc. (PACS) Q3 2025 Earnings Call Transcript

Nov 19, 2025, 7:43 PM EST - 2 months ago

PACS Group, Inc. (PACS) Q3 2025 Earnings Call Transcript


PACS Group, Inc. Reports Third Quarter 2025 Results

Nov 19, 2025, 4:30 PM EST - 2 months ago

PACS Group, Inc. Reports Third Quarter 2025 Results


DrabCrab5
DrabCrab5 Feb. 3 at 6:39 PM
$PACS a fine shelter in the absolute shit show that is today across tech / software.
0 · Reply
DrabCrab5
DrabCrab5 Jan. 30 at 9:03 PM
$PACS now that we’re back down in the mid $30’s thought it was as good a time as ever to share an updated version of the below. A lot will depend on the 2026 outlook, but I’m not sure why this wouldn’t trade back up to the mid $40’s in due time.
1 · Reply
Beansboy
Beansboy Jan. 29 at 3:18 PM
$PACS seriously where is the bottom here? How can it sell off like this every single day for 3 weeks straight?
2 · Reply
Beansboy
Beansboy Jan. 28 at 2:59 PM
$PACS such blatant price manipulation. Notice how every single time it’s green it’s immediately knocked significantly back into red. Been doing this nearly every single day since 1/12. Couldn’t be anymore obvious. Someone is trying to keep the share price suppressed.
1 · Reply
Beansboy
Beansboy Jan. 27 at 9:31 PM
$PACS I think this has been unfairly beaten down. Going to guess it’s a mix of profit taking and market makers pushing this down easily for a cheaper entry. Hope it can get back to $40 on its own. Also hope they give us some preliminary Q4 2025 results in Feb.
0 · Reply
mrtatham
mrtatham Jan. 26 at 7:07 AM
$PACS so you’re telling me that the short interest for March 20 is sitting almost 96% in $25 Puts????? They are 100% disclosing information about the investigation next earnings that is not going to be good. Insiders loaded to the gills on puts.
1 · Reply
DrabCrab5
DrabCrab5 Jan. 21 at 7:04 PM
$PACS company announced the acquisition of 3 new facilities as well as the underlying real estate of two of those facilities. They also exercised the right to acquire the real estate for two separate facilities they already owned the operations of. Would love to see a few more facility tuck ins before Q4 results are announced.
0 · Reply
DrabCrab5
DrabCrab5 Jan. 20 at 8:53 PM
$PACS pretty confused at this point… names I follow that are much more sensitive to broader economic conditions, tariffs, etc. are not down near this much. Should be holding up better as a defensive, non-discretionary name but so be it I guess.
1 · Reply
DrabCrab5
DrabCrab5 Jan. 20 at 6:34 PM
$PACS a 15% drop off the high this week vs. $ENSG at more like 2.5% off its weekly high is feeling prettyyy egregious
0 · Reply
inksquid
inksquid Jan. 20 at 2:36 PM
$PACS Put options are cheap
0 · Reply
WallStreetBuyDip
WallStreetBuyDip Jan. 19 at 5:14 PM
$PACS Massive volume spike on Jan 14 with 1.96M shares traded, well over double the average. Price dropped from $42.13 to $38.77. Smart money waits for H% to cool down before considering entry.
0 · Reply
Ba1man
Ba1man Jan. 19 at 3:15 PM
$PACS The target 50-65$ by next year
0 · Reply
Ba1man
Ba1man Jan. 19 at 3:14 PM
0 · Reply
SuperGreenToday
SuperGreenToday Jan. 16 at 11:38 PM
$PACS Share Price: $38.77 Contract Selected: Jun 18, 2026 $40 Calls Buy Zone: $5.18 – $6.41 Target Zone: $8.83 – $10.79 Potential Upside: 61% ROI Time to Expiration: 152 Days | Updates via https://fxcapta.com/stockinfo/
0 · Reply
txandco
txandco Jan. 16 at 4:35 PM
$PACS Sold some to load up on RILY to ride the turnaround
0 · Reply
DrabCrab5
DrabCrab5 Jan. 15 at 6:12 PM
$PACS also interesting divergence between PACS and $ENSG
0 · Reply
DrabCrab5
DrabCrab5 Jan. 15 at 4:06 PM
$PACS vast majority of January options expire tomorrow. Could certainly help explain the move yesterday. Let’s see how the stock reacts on Monday.
1 · Reply
DrabCrab5
DrabCrab5 Jan. 14 at 8:08 PM
$PACS I think the pushback on your point about higher acuity patients is that PACS is, generally speaking, not diagnosing the patients. Hospitals / doctors are diagnosing the patients and subsequently refer patients to PACS and other skilled nursing facilities. I think the point the CEO was trying to make is that many of their acquired facilities don’t have the capabilities, equipment, or expertise to take on higher acuity patients and so PACS brings the investment and necessary expertise so that acquired facilities can take on more valuable higher acuity work over time.
1 · Reply
seekingyield1
seekingyield1 Jan. 14 at 7:09 PM
$PACS I sold this to make room for some other things, figured 100% over a couple of months was good enough for me. But my rough read on the presentation: -- a primary use of capital will be acquiring real estate and shifting the structure closer to that of ENSG -- they did not dismiss the short report, but said they thoroughly addressed the issues. The implication being there were in fact issues and we do still have the DOJ and other gov investigations that need resolution What I did not love is them continuously alluding to higher acuity patients being the driver of their profits, particularly when turning an acquisition around. This sounds a lot like their 'secret sauce' is arriving and diagnosing patients with as many issues as possible - ie increasing complexity - without any substantial change to care and thus dramatically increasing reimbursements from Medicare/Medicaid at 100% margin. This was literally the core of the short report https://www.wsj.com/health/healthcare/unitedhealth-medicare-senate-report-706664fd?gaa_at=eafs&gaa_n=AWEtsqe3RoWchIXH5KecK-mmOVOOgL7B4LWNKRozq7o9y4GHKkv9_o8__uzAlQ39WiI%3D&gaa_ts=6967ec6e&gaa_sig=AaVRp5o7v3xQLe5jEKnrPO3S7a0camIDS1QkV48QOmdXIPrwzzGf0kTfMuX7Ipuy7WcbT7eqC5THK4RwoWvHsA%3D%3D
2 · Reply
forallthedogs
forallthedogs Jan. 14 at 6:55 PM
$PACS this is disappointing
1 · Reply
forallthedogs
forallthedogs Jan. 14 at 6:35 PM
$PACS damn was the event that bad why is it goin down ?
0 · Reply
irishstu
irishstu Jan. 14 at 8:54 AM
$PACS Pretty harmless presentation. No new concrete update over what we already knew. Their mention of AI development was a bit washy, some clear information on acquisitions in the pipeline would have a much more positive effect imo. Would have been good to have some update on their remains overhang, the DOJ investigation.
2 · Reply